TFA
NVAX icon

Toth Financial Advisory’s Novavax NVAX Stock Holding History

Toth Financial Advisory’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,000
Closed -$21.7K – 773
2023
Q3 		$21.7K Buy
3,000
+2,000
+200% +$16K ﹤0.01% 359
2023
Q2 		$7.43K Buy
+1,000
New +$7.86K ﹤0.01% 508

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Toth Financial Advisory's NVAX Position: Q4 2023 in Review

Toth Financial Advisory sold out of Novavax (NVAX) in Q4 2023, closing a stake of 3,000 shares — an estimated $21.7K sold.

Toth Financial Advisory first reported a position in NVAX in Q2 2023 and held it in 2 quarters. The position peaked at $21.7K in Q3 2023. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • Toth Financial Advisory reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • Toth Financial Advisory sold 3,000 Novavax shares in Q4 2023, an estimated $21.7K.
  • Toth Financial Advisory first reported a position in Novavax in Q2 2023 and held it in 2 quarters.
  • Toth Financial Advisory's Novavax position peaked at $21.7K in Q3 2023.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on Toth Financial Advisory's 13F filing for Q4 2023, filed 26 Jan 2024.